Morning Overview on MSN
Duke study: Nasal swab may detect Alzheimer’s changes before symptoms
A team linked to Duke University and the UNC Alzheimer’s Disease Research Center has found that a simple brush swab of the nasal lining can pick up molecular and immune cell changes tied to ...
Health economics analysis highlights the economic burden of late-stage leptomeningeal metastases (LM) and the potential value ...
Morning Overview on MSN
Study links glymphatic system dysfunction to hallucinations
Researchers studying a rare genetic condition tied to high psychosis risk have found that the brain’s waste-clearing plumbing ...
Additional biomarker analysis reveals higher CSF levels of DOPA decarboxylase (DDC – an emerging PD biomarker) at baseline with a reduction ...
Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher diseaseParis, March 18, 2026. The US Food and Drug ...
Flosonics Medical, maker of FloPatch, the world's first wireless, wearable Doppler ultrasound for critical care, today announced the peer-reviewed publication of the Safe and Fluid Effective ...
The landscape of dementia diagnostics is undergoing a paradigm shift with the emergence of liquid biopsy, blood-based biomarkers (BBMs), and blood-derived ...
The AI adverse event problem nobody is talking about reveals risks in FDA-cleared surgical devices lacking robust clinical trials.
The study ties first-trimester Oropouche infection to severe fetal neurodevelopmental anomalies and urges RT-PCR within 2-7 ...
Using single-cell sequencing, researchers found distinct immune profiles in different CNS tumors, highlighting its potential as a prognostic tool.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results